Multifunctional theranostic gold nanoparticles for targeted CT imaging and photothermal therapy

Contrast Media and Molecular Imaging

Volumn 9, Issue 1, 2014, Pages 53-61

  Curry, Taeyjuana ^a   Kopelman, Raoul ^a   Shilo, Malka ^b   Popovtzer, Rachela ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

Computed tomography (CT); Gold nanoparticles; Photothermal therapy (PTT)

Indexed keywords

CONTRAST MEDIUM; GOLD NANOPARTICLE; IODINE; PHOTOSENSITIZING AGENT;

ARTICLE; BREAST CANCER; CANCER CELL; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG CONJUGATION; HEAT; IMAGE GUIDED RADIOTHERAPY; MEDIATOR; MOLECULAR IMAGING; NONHUMAN; PHOTOTHERAPY; PHOTOTHERMAL THERAPY; PRIORITY JOURNAL; RADIATION ATTENUATION; RADIATION DOSE; RADIATION EXPOSURE; X RAY;

COMPUTED TOMOGRAPHY (CT); GOLD NANOPARTICLES; PHOTOTHERMAL THERAPY (PTT);

GOLD; HUMANS; HYPERTHERMIA, INDUCED; METAL NANOPARTICLES; NEOPLASMS; PHOTOTHERAPY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84893119677     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.1563     Document Type: Article

References (81)

1. Boisselier E, Astruc D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 2009; 38(6): 1759-1782.
2. Huang HC, Barua S, Sharma G, Dey SK, Rege K. Inorganic nanoparticles for cancer imaging and therapy. J Control Rel 2011; 155(3): 344-357.
3. Liu DB, Wang Z, Jiang XY. Gold nanoparticles for the colorimetric and fluorescent detection of ions and small organic molecules. Nanoscale 2011; 3(4): 1421-1433.
4. Jain S, Hirst DG, O'Sullivan JM. Gold nanoparticles as novel agents for cancer therapy. Br J Radiol 2012; 85(1010): 101-113.
5. Norman RS, Stone JW, Gole A, Murphy CJ, Sabo-Attwood TL. Targeted photothermal lysis of the pathogenic bacteria, Pseudomonas aeruginosa, with gold nanorods. Nano Lett 2008; 8(1): 302-306.
6. von Maltzahn G, Park JH, Agrawal A, et al. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res 2009; 69(9): 3892-3900.
7. Minati L, Antonini V, Torrengo S, et al. Sustained in vitro release and cell uptake of doxorubicin adsorbed onto gold nanoparticles and covered by a polyelectrolyte complex layer. Int J Pharm 2012; 438(1-2): 45-52.
8. Rand D, Ortiz V, Liu Y, et al. Nanomaterials for X-ray imaging: gold nanoparticle enhancement of X-ray scatter imaging of hepatocellular carcinoma. Nano Lett 2011; 11(7): 2678-2683.
9. Popovtzer R, Agrawal A, Kotov NA, et al. Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Lett 2008; 8(12): 4593-4596.
10. Shilo M, Reuveni T, Motiei M, Popovtzer R. Nanoparticles as computed tomography contrast agents: current status and future perspectives. Nanomedicine 2012; 7(2): 257-269.
11. Jakobsohn K, Motiei M, Sinvani M, Popovtzer R. Towards real-time detection of tumor margins using photothermal imaging of immune-targeted gold nanoparticles. Int J Nanomed 2012; 7: 4707-4713.
12. Ankri R, Peretz V, Motiei M, Popovtzer R, Fixler D. A new method for cancer detection based on diffusion reflection measurements of targeted gold nanorods. Int J Nanomed 2012; 7: 449-455.
13. Ankri R, Meiri A, Lau SI, Motiei M, Popovtzer R, Fixler D. Intercoupling surface plasmon resonance and diffusion reflection measurements for real-time cancer detection. J Biophotonics 2013; 6(2): 188-196.
14. Ankri R, Duadi H, Motiei M, Fixler D. In-vivo Tumor detection using diffusion reflection measurements of targeted gold nanorods - a quantitative study. J Biophotonics 2012; 5(3): 263-273.
15. Link S, El-Sayed MA. Spectral properties and relaxation dynamics of surface plasmon electronic oscillations in gold and silver nanodots and nanorods. J Phys Chem B 1999; 103(40): 8410-8426.
16. El-Sayed MA. Some interesting properties of metals confined in time and nanometer space of different shapes. Acc Chem Res 2001; 34(4): 257-264.
17. Yu SB, Watson AD. Metal-based X-ray contrast media. Chem Rev 1999; 99(9): 2353-2377.
18. Xu CJ, Tung GA, Sun SH. Size and concentration effect of gold nanoparticles on X-ray attenuation as measured on computed tomography. Chem Mater 2008; 20(13): 4167-4169.
19. Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 2010; 9(8): 615-627.
20. Hallouard F, Anton N, Choquet P, Constantinesco A, Vandamme T. Iodinated blood pool contrast media for preclinical X-ray imaging applications - a review. Biomaterials 2010; 31(24): 6249-6268.
21. Allkemper T, Bremer C, Matuszewski L, Ebert W, Reimer P. Contrast-enhanced blood-pool MR angiography with optimized iron oxides: effect of size and dose on vascular contrast enhancement in rabbits. Radiology 2002; 223(2): 432-438.
22. Beija M, Li Y, Duong HT, et al. Polymer-gold nanohybrids with potential use in bimodal MRI/CT: enhancing the relaxometric properties of Gd(III) complexes. J Mater Chem 2012; 22(40): 21382-21386.
23. Xie MR, Ding L, You ZW, Gao DY, Yang GD, Han HJ. Robust hybrid nanostructures comprising gold and thiol-functionalized polymer nanoparticles: facile preparation, diverse morphologies and unique properties. J Mater Chem 2012; 22(28): 14108-1418.
24. Han SY, Guo QH, Xu MM, et al. Tunable fabrication on iron oxide/Au/Ag nanostructures for surface enhanced Raman spectroscopy and magnetic enrichment. J Colloid Interface Sci 2012; 378: 51-57.
25. Guo X, Zhang Q, Sun YH, Zhao Q, Yang J. Lateral etching of core-shell Au@metal nanorods to metal-tipped Au nanorods with improved catalytic activity. ACS Nano 2012; 6(2): 1165-1175.
26. Tkachenko AG, Xie H, Liu YL, et al. Cellular trajectories of peptide-modified gold particle complexes: comparison of nuclear localization signals and peptide transduction domains. Bioconjug Chem 2004; 15(3): 482-490.
27. Nativo P, Prior IA, Brust M. Uptake and intracellular fate of surface-modified gold nanoparticles. ACSNano 2008; 2(8): 1639-1644.
28. Link S, El-Sayed MA. Shape and size dependence of radiative, non-radiative and photothermal properties of gold nanocrystals. Int Rev Phys Chem 2000; 19(3): 409-453.
29. Chial HJ, Thompson HB, Splittgerber AG. A spectral study of the charge forms of Coomassie Blue-G. Anal Biochem 1993; 209(2): 258-266.
30. Ghosh P, Han G, De M, Kim CK, Rotello VM. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 2008; 60(11): 1307-1315.
31. Arvizo R, Bhattacharya R, Mukherjee P. Gold nanoparticles: opportunities and challenges in nanomedicine. Exp Opin Drug Deliv 2010; 7(6): 753-763.
32. Zhang GD, Yang Z, Lu W, et al. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials 2009; 30(10): 1928-1936.
33. Lasagna-Reeves C, Gonzalez-Romero D, Barria MA, et al. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Commun 2010; 393(4): 649-655.
34. Balasubramanian SK, Jittiwat J, Manikandan J, Ong CN, Yu LE, Ong WY. Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. Biomaterials 2010; 31(8): 2034-2042.
35. Lipka J, Semmler-Behnke M, Sperling RA, et al. Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials 2010; 31(25): 6574-6581.
36. Chanda N, Kattumuri V, Shukla R, et al. Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity. Proc Natl Acad Sci U S A 107(19): 8760-8765.
37. Kunzmann A, Andersson B, Thurnherr T, Krug H, Scheynius A, Fadeel B. Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta, Gen Subj 2011; 1810(3): 361-373.
38. El-Sayed IH. Nanotechnology in head and neck cancer: the race is on. CurrOncol Rep 2010; 12(2): 121-128.
39. Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 2010; 40(4): 328-346.
40. Cobley CM, Au L, Chen JY, Xia YN. Targeting gold nanocages to cancer cells for photothermal destruction and drug delivery. Exp Opin Drug Deliv 2010; 7(5): 577-587.
41. Zhang XD, Wu HY, Wu D, et al. Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int J Nanomed 2010; 5: 771-781.
42. Sherman AI, Ter-Pogossian M. Lymph-node concentration of radioactive colloidal gold following interstitial injection. Cancer 1953; 6(6): 1238-1240.
43. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005; 1(3): 325-327.
44. Kojima C, Umeda Y, Ogawa M, Harada A, Magata Y, Kono K. X-ray computed tomography contrast agents prepared by seeded growth of gold nanoparticles in PEGylated dendrimer. Nanotechnology 2010; 21(24): 245-251.
45. Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 2006; 79(939): 248-253.
46. Ghaghada KB, Badea CT, Karumbaiah L, et al. Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imaging. Acad Radiol 2011; 18(1): 20-30.
47. Hainfeld JF, O'Connor MJ, Dilmanian FA, Slatkin DN, Adams DJ, Smilowitz HM. Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions. Br J Radiol 2011; 84(1002): 526-533.
48. Chanda N, Kattumuri V, Shukla R, et al. Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity. Proc Natl Acad Sci U S A 2010; 107(19): 8760-8765.
49. Wang H, Zheng LF, Peng C, Shen MW, Shi XY, Zhang GX. Folic acid-modified dendrimer-entrapped gold nanoparticles as nanoprobes for targeted CT imaging of human lung adencarcinoma. Biomaterials 2012; 34(2): 470-480.
50. Sanz J, Fayad ZA. Imaging of atherosclerotic cardiovascular disease. Nature 2008; 451(7181): 953-957.
51. Reuveni T, Motiei M, Romman Z, Popovtzer A, Popovtzer R. Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study. Int J Nanomed 2011; 6: 2859-2864.
52. Weber RJ, Taylor BR, Engelman DE. Laser-induced tissue reactions and dermatology. In Basics in Dermatological Laser Applications, Allemann IB, Goldberg DJ (eds). Basel: Karger, 2011; 24-34.
53. Paithankar DY, Ross EV, Saleh BA, Blair MA, Graham BS. Acne treatment with a 1, 450 nm wavelength laser and cryogen spray cooling. Lasers Surg Med 2002; 31(2): 106-114.
54. Majaron B, Verkruysse W, Tanenbaum BS, et al. Combining two excitation wavelengths for pulsed photothermal profiling of hypervascular lesions in human skin. Phys Med Biol 2000; 45(7): 1913-1922.
55. Heger M, Salles II, Bezemer R, et al. Laser-induced primary and secondary hemostasis dynamics and mechanisms in relation to selective photothermolysis of port wine stains. J Dermatol Sci 2011; 63(3): 139-147.
56. Basso FG, Pansani TN, Turrioni APS, Bagnato VS, Hebling J, de Souza Costa CA. In vitro wound healing improvement by low-level laser therapy application in cultured gingival fibroblasts. Int J Dent 2012; 2012: 719452.
57. Santos NRS, Sobrinho JBdM, Almeida PF, et al. Influence of the combination of infrared and red laser light on the healing of cutaneous wounds infected by Staphylococcus aureus. Photomed Laser Surg 2011; 29(3): 177-182.
58. Cafaro A, Albanese G, Arduino PG, et al. Effect of low-level laser irradiation on unresponsive oral lichen planus: early preliminary results in 13 patients. Photomed Laser Surg 2010; 28(suppl 2): S99-103.
59. Barton JK, Rollins A, Yazdanfar S, Pfefer TJ, Westphal V, Izatt JA. Photothermal coagulation of blood vessels: a comparison of high-speed optical coherence tomography and numerical modelling. Phys Med Biol 2001; 46(6): 1665-1678.
60. McMillan K, Perepelitsyn I, Wang Z, Shapshay SM. Tumor growth inhibition and regression induced by photothermal vascular targeting and angiogenesis inhibitor retinoic acid. Cancer Lett 1999; 137(1): 35-44.
61. Curry T, Smith R, Kopelman R. Photothermal therapy of cancer cells mediated by blue hydrogel nanoparticles. Nanomedicine 2013, doi: 10.2217/nnm.12.190.
62. Pustovalov V, Babenko V. Computer modeling of optical properties of gold ellipsoidal nanoparticles at laser radiation wavelengths. Laser Phys Lett 2005; 2(2): 84-88.
63. Letfullin RR, Joenathan C, George TF, Zharov VP. Laser-induced explosion of gold nanoparticles: potential role for nanophotothermolysis of cancer. Nanomedicine 2006; 1(4): 473-480.
64. Jain PK, Lee KS, El-Sayed IH, El-Sayed MA. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. J Phys Chem B 2006; 110(14): 7238-7248.
65. Iancu C, Mocan L. Advances in cancer therapy through the use of carbon nanotube-mediated targeted hyperthermia. Int J Nanomed 2011; 6: 1675-1684.
66. Kirui DK, Rey DA, Batt CA. Gold hybrid nanoparticles for targeted phototherapy and cancer imaging. Nanotechnology 2010; 21(10): 105105-105115.
67. Choi J, Yang J, Bang D, et al. Targetable gold nanorods for epithelial cancer therapy guided by near-IR absorption imaging. Small 2012; 8(5): 746-753.
68. El-Sayed IH, Huang XH, El-Sayed MA. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett 2006; 239(1): 129-135.
69. Ray PC, Khan SA, Singh AK, Senapati D, Fan Z. Nanomaterials for targeted detection and photothermal killing of bacteria. Chem Soc Rev 2012; 41(8): 3193-3209.
70. Pissuwan D, Cortie CH, Valenzuela SM, Cortie MB. Functionalised gold nanoparticles for controlling pathogenic bacteria. Trends Biotechnol 2010; 28(4): 207-213.
71. Qian W, Murakami M, Ichikawa Y, Che Y. Highly efficient and controllable PEGylation of gold nanoparticles prepared by femtosecond laser ablation in water. J Phys Chem C 2011; 115(47): 23293-23298.
72. Curry TY. Nanoparticles for Biomedical Applications: Photothermal Therapy and Nuclear Delivery. PhD. Thesis, University of Michigan, Physics: Ann Arbor, MI, 2012; 154.
73. Yuan H, Khoury CG, Wilson CM, Grant GA, Bennett AJ, Vo-Dinh T. In vivo particle tracking and photothermal ablation using plasmon-resonant gold nanostars. Nanomed Nanotechnol Biol Med 2012; 8(8): 1355-1363.
74. Zharov VP, Galitovskaya EN, Johnson C, Kelly T. Synergistic enhancement of selective nanophotothermolysis with gold nanoclusters: potential for cancer therapy. Lasers Surg Med 2005; 37(4): 329-329.
75. Nam J, Won N, Jin H, Chung H, Kim S. pH-Induced aggregation of gold nanoparticles for photothermal cancer therapy. J Am Chem Soc 2009; 131(38): 13639-13645.
76. Huhn D, Govorov A, Gil PR, Parak WJ. Photostimulated Au nanoheaters in polymer and biological media: characterization of mechanical destruction and boiling. Adv Funct Mater 2012; 22(2): 294-303.
77. Murthy AK, Stover RJ, Borwankar AU, et al. Equilibrium gold nanoclusters quenched with biodegradable polymers. ACS Nano 2013; 7(1): 239-251.
78. Coronado EA, Encina ER, Stefani FD. Optical properties of metallic nanoparticles: manipulating light, heat and forces at the nanoscale. Nanoscale 2011; 3(10): 4042-4059.
79. Orringer DA, Chen T, Huang DL, et al. The brain tumor window model: a combined cranial window and implanted glioma model for evaluating intraoperative contrast agents. Neurosurgery 2010; 66(4): 736-743.
80. Koo YEL, Reddy GR, Bhojani M, et al. Brain cancer diagnosis and therapy with nanoplatforms. Adv Drug Deliv Rev 2006; 58(14): 1556-1577.
81. Ross B, Rehemtulla A, Koo YEL, et al. Photonic and magnetic nanoexplorers for biomedical use: from subcellular imaging to cancer diagnostics and therapy. Conference on Nanobiophotonics and Biomedical Applications, San Jose, CA, 2004; 76-83.